Author

Charlotte Albæk Thrue

Observed names: C. A. Thrue, C. Thrue, C.A. Thrue, CA Thrue, Charlotte A Thrue, Charlotte A. Thrue, Charlotte Albaek Thrue, Charlotte Albæk, Thrue, C, Thrue, Charlotte Albæk

Observed institutions: University of Copenhagen, University of Washington, Medical University of Graz, Aalborg University Hospital, Herlev Hospital, The Netherlands Cancer Institute, University of Catania, Aalborg University

ORCID: 0000-0003-1219-3447

Observed ORCID: 0000-0003-1219-3447

OpenAlex ID: A5083752386

A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth

2008 · Lee M. Greenberger, Ivan D. Horak, et al. · Molecular Cancer Therapeutics · 245

PDF

TIL therapy broadens the tumor-reactive CD8+T cell compartment in melanoma patients

2012 · Pia Kvistborg, Chengyi Jenny Shu, et al. · OncoImmunology · 178

PDF

Dissection of T-cell Antigen Specificity in Human Melanoma

2012 · Rikke Sick Andersen, Charlotte Albæk Thrue, et al. · Cancer Research · 158

T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors

2014 · Rikke Lyngaa, Natasja Wulff Pedersen, et al. · Clinical Cancer Research · 100

Long Noncoding RNA Expression during Human B-Cell Development

2015 · Andreas Petri, Karen Dybkær, et al. · PLoS ONE · 99

PDF

SPC3042: a proapoptotic survivin inhibitor

2008 · Jens Bo Hansen, Niels Fisker, et al. · Molecular Cancer Therapeutics · 99

Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche

2018 · Shokichi Tsukamoto, Marianne B. Løvendorf, et al. · Leukemia · 40

Knockdown of Circular RNAs Using LNA-Modified Antisense Oligonucleotides

2022 · Marianne Bengtson Løvendorf, Anja Holm, et al. · Nucleic Acid Therapeutics · 25

Antisense Knockdown of PKC-α Using LNA-Oligos

2003 · Jens Bo Hansen, Majken Westergaard, et al. · Nucleosides Nucleotides & Nucleic Acids · 14

HOXB-AS3 Regulates Cell Cycle Progression and Interacts with the Drosophila Splicing Human Behavior (DSHB) Complex in NPM1-Mutated Acute Myeloid Leukemia

2016 · Dimitrios Papaioannou, Andreas Petri, et al. · Blood · 4

Discovery of CD8 T cell epitopes in Merkel cell polyomavirus through combinatorial encoding with MHC multimers

2013 · Rikke Lyngaa, Natasja W Pedersen, et al. · Journal for ImmunoTherapy of Cancer · 2

PDF

SPC2968—A novel Hif-1α antagonist for treatment of clear cell renal cell carcinoma

2006 · M. Westergaard, H. F. Hansen, et al. · Journal of Clinical Oncology · 2

706 In vitro and in vivo efficacy of a HIF-1alpha-antisense oligonucleotide containing locked nucleic acids

2003 · A. Hoeg, C. Thrue, et al. · European Journal of Cancer Supplements · 2

SPC2996—A Bcl-2 RNA antagonist being studied in chronic lymphocytic leukemia

2006 · B. J. Hansen, M. Westergaard, et al. · Journal of Clinical Oncology · 1

SPC2996 - A New Bcl-2 Inhibitor for the Treatment of CLL.

2005 · Phil Kearney, Majken Westergaard, et al. · Blood · 1

216 SPC-2004 — a potent locked nucleic acid drug against Bcl-2 in cancer

2004 · B. Hansen, M. Westergaard, et al. · European Journal of Cancer Supplements · 1

Supplementary Table S3 from T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors